Skip to main content

Alterome Therapeutics

San Diego, United States

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

$132.0M raised
Apr 2024
Series B

Top Investors

Blue OwlGoldman SachsOrbiMedVida VenturesCanaan Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alterome Therapeutics

How much funding has Alterome Therapeutics raised?
Alterome Therapeutics has raised $132.0M in total funding. The most recent round was Series B. The last funding was announced in April 2024.
Who are Alterome Therapeutics's investors?
Alterome Therapeutics's investors include Blue Owl, Goldman Sachs, OrbiMed, Vida Ventures, Canaan Partners.
Where is Alterome Therapeutics headquartered?
Alterome Therapeutics is headquartered in San Diego, United States.
What does Alterome Therapeutics do?
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
What stage is Alterome Therapeutics at?
Alterome Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Alterome Therapeutics — Funding & Investors." VCBacked, April 3, 2024, https://www.vcbacked.co/company/alterome-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2024). Alterome Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/alterome-therapeutics
Wikipedia (cite web)
{{cite web |title=Alterome Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alterome-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .